Cas no 51616-99-0 (2-cyclopentylpiperidine)
2-cyclopentylpiperidine Chemical and Physical Properties
Names and Identifiers
-
- Piperidine, 2-cyclopentyl-
- 2-cyclopentylpiperidine
- C91563
- DTXSID60405219
- SCHEMBL4783327
- EN300-1233878
- 51616-99-0
- AKOS001476987
-
- Inchi: 1S/C10H19N/c1-2-6-9(5-1)10-7-3-4-8-11-10/h9-11H,1-8H2
- InChI Key: IXTALOBLEDXRNT-UHFFFAOYSA-N
- SMILES: N1CCCCC1C1CCCC1
Computed Properties
- Exact Mass: 153.15187
- Monoisotopic Mass: 153.151749610g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 11
- Rotatable Bond Count: 1
- Complexity: 116
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.5
- Topological Polar Surface Area: 12?2
Experimental Properties
- PSA: 12.03
2-cyclopentylpiperidine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | C993278-10mg |
2-cyclopentylpiperidine |
51616-99-0 | 10mg |
$ 133.00 | 2023-04-17 | ||
| TRC | C993278-50mg |
2-cyclopentylpiperidine |
51616-99-0 | 50mg |
$ 287.00 | 2023-04-17 | ||
| TRC | C993278-100mg |
2-cyclopentylpiperidine |
51616-99-0 | 100mg |
$ 275.00 | 2022-06-06 | ||
| A2B Chem LLC | AZ31577-50mg |
Piperidine, 2-cyclopentyl- |
51616-99-0 | 95% | 50mg |
$134.00 | 2024-04-19 | |
| A2B Chem LLC | AZ31577-100mg |
Piperidine, 2-cyclopentyl- |
51616-99-0 | 95% | 100mg |
$183.00 | 2024-04-19 | |
| A2B Chem LLC | AZ31577-250mg |
Piperidine, 2-cyclopentyl- |
51616-99-0 | 95% | 250mg |
$246.00 | 2024-04-19 | |
| A2B Chem LLC | AZ31577-500mg |
Piperidine, 2-cyclopentyl- |
51616-99-0 | 95% | 500mg |
$429.00 | 2024-04-19 | |
| A2B Chem LLC | AZ31577-1g |
Piperidine, 2-cyclopentyl- |
51616-99-0 | 95% | 1g |
$561.00 | 2024-04-19 | |
| A2B Chem LLC | AZ31577-2.5g |
Piperidine, 2-cyclopentyl- |
51616-99-0 | 95% | 2.5g |
$1065.00 | 2024-04-19 | |
| A2B Chem LLC | AZ31577-5g |
Piperidine, 2-cyclopentyl- |
51616-99-0 | 95% | 5g |
$1560.00 | 2024-04-19 |
2-cyclopentylpiperidine Related Literature
-
Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
-
3. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticlesAdrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236
-
Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
-
Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
Additional information on 2-cyclopentylpiperidine
Comprehensive Overview of 2-Cyclopentylpiperidine (CAS No. 51616-99-0): Properties, Applications, and Industry Insights
2-Cyclopentylpiperidine (CAS No. 51616-99-0) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research due to its unique structural properties. This bicyclic amine, featuring a piperidine ring fused with a cyclopentyl group, serves as a versatile intermediate in synthetic chemistry. Its molecular formula, C10H19N, and molecular weight of 153.27 g/mol make it a valuable building block for designing bioactive molecules. Researchers often explore its potential in drug discovery, particularly for central nervous system (CNS) targets, given its ability to modulate lipophilicity and bioavailability.
In recent years, the demand for 2-cyclopentylpiperidine derivatives has surged, driven by trends in personalized medicine and the search for novel small-molecule therapeutics. Online searches for "piperidine-based compounds in drug development" or "cyclopentyl group effects on pharmacokinetics" reflect growing industry interest. The compound’s balanced hydrophobicity, attributed to the cyclopentyl moiety, enhances membrane permeability—a critical factor in optimizing blood-brain barrier penetration for neurological applications. This aligns with current hot topics like neurodegenerative disease research and precision oncology, where structural analogs of this compound are being investigated.
Synthetic routes to 51616-99-0 typically involve reductive amination or ring-closure strategies, with recent advancements focusing on green chemistry principles. A 2023 study highlighted its role in catalyzing asymmetric reactions, addressing the popular search query "sustainable synthesis of N-heterocycles." The compound’s crystalline form (melting point ~45–50°C) and solubility profile in organic solvents like ethanol and dichloromethane make it practical for industrial-scale production. Analytical techniques such as GC-MS and HPLC are commonly employed for purity verification, ensuring compliance with stringent regulatory standards for pharmaceutical intermediates.
Beyond pharmaceuticals, 2-cyclopentylpiperidine finds niche applications in material science, particularly in designing liquid crystal displays (LCDs) and ionic liquids. Its thermal stability and conformational flexibility contribute to tunable mesomorphic properties—a subject frequently searched alongside "advanced organic electronic materials." Additionally, agrochemical researchers leverage its scaffold to develop next-generation crop protection agents, capitalizing on the cyclopentyl group’s resistance to metabolic degradation.
From a commercial perspective, suppliers of CAS 51616-99-0 emphasize batch-to-batch consistency and scalability, responding to market queries like "reliable sources of high-purity piperidine derivatives." Storage recommendations typically include inert atmospheres at 2–8°C to prevent oxidation, a detail crucial for laboratories focusing on long-term stability studies. With patent analyses revealing increased filings for 2-cyclopentylpiperidine-containing formulations between 2020–2024, the compound’s intellectual property landscape remains dynamic, particularly in jurisdictions with robust generic drug pipelines.
Emerging computational approaches, including molecular docking simulations and QSAR modeling, have further illuminated the compound’s interactions with biological targets. This ties into trending searches about "AI-driven drug discovery" and "in silico ADMET prediction." As regulatory agencies prioritize structure-activity relationship (SAR) data, documented studies on 51616-99-0’s stereochemical influences provide valuable reference points for medicinal chemists navigating FDA/EMA submission requirements.
The environmental footprint of 2-cyclopentylpiperidine production has also entered mainstream discourse, coinciding with searches for "biodegradable heterocyclic compounds." Lifecycle assessments suggest that modern catalytic hydrogenation methods reduce waste generation compared to traditional stoichiometric processes—an eco-conscious advantage highlighted in ESG-focused supply chain audits. Such advancements position this compound favorably within the green chemistry paradigm that dominates contemporary chemical manufacturing dialogues.
Looking ahead, the intersection of high-throughput screening technologies and fragment-based drug design may unlock new therapeutic applications for 2-cyclopentylpiperidine scaffolds. Its compatibility with click chemistry protocols and bioorthogonal reactions—frequent topics in recent scientific literature—enhances its utility in probe development for diagnostic imaging. These cutting-edge applications ensure sustained relevance in both academic and industrial settings, solidifying CAS 51616-99-0 as a compound of enduring scientific and commercial significance.
51616-99-0 (2-cyclopentylpiperidine) Related Products
- 2051-28-7(1,2,3,4,4a,5,6,7,8,8a-decahydroquinoline)
- 6287-19-0(2,4-Dimethylpiperidine)
- 280-38-6(2-Azabicyclo[2.2.2]octane)
- 912771-29-0(2-(piperidin-3-yl)azepane)
- 383128-00-5(2-cyclopropylpiperidine)
- 21974-48-1(2,4,6-trimethylpiperidine)
- 177-17-3(6-azaspiro4.5decane)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)